Efficacy of Neridronic Acid IV and IM in Improving BMD and Reducing Fracture Risk in Postmenopausal Osteoporosis.

Osteoporosis is a major health concern that is associated with an increased risk of first and subsequent bone fractures. Untreated osteoporosis results in considerable morbidity. Currently, bisphosphonates are the mainstay of treatment for osteoporosis and the aim of this study was to assess the effects of intravenous (IV) and intramuscular (IM) neridronate (NE) on femoral/lumbar bone mineral density (BMD). Data were collected on a ge, weight,